Modulation of gene expression in transgenic mouse hearts overexpressing calsequestrin
- 14 July 2002
- journal article
- Published by Elsevier in Cell Calcium
- Vol. 32 (1) , 21-29
- https://doi.org/10.1016/s0143-4160(02)00096-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cardiac Ankyrin Repeat Protein Is a Novel Marker of Cardiac HypertrophyHypertension, 2000
- Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrinThe Journal of Physiology, 2000
- Modulation of focal and global Ca2+ release in calsequestrin‐overexpressing mouse cardiomyocytesThe Journal of Physiology, 2000
- Messenger RNA expression and immunological quantification of phospholamban and SR-Ca2+-ATPase in failing and nonfailing human heartsCardiovascular Research, 2000
- Regulation of GATA-4 and AP-1 in transgenic mice overexpressing cardiac calsequestrinCell Calcium, 1999
- Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin.Journal of Clinical Investigation, 1998
- Cloning from a mouse osteoblastic cell line of a set of transforming‐growth‐factor‐β1‐regulated genes, one of which seems to encode a follistatin‐related polypeptideEuropean Journal of Biochemistry, 1993
- Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain ReactionScience, 1992
- Left Ventricular Hypertrophy and Mortality – Results from the Framingham StudyCardiology, 1992
- Amino-acid sequence of a Ca2+ + Mg2+ -dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequenceNature, 1985